Andrew Witty — who became UnitedHealth Group’s CEO in 2021 — is stepping down from the top post due to personal reasons after years leading large health care companies. During the tail end ...

Andrew Witty was the chief executive officer of UnitedHealth Group, one of the world's biggest healthcare corporations. Sir Andrew Witty is a senior British business leader who is well known for ...

Andrew Witty’s departure as CEO is due to "personal reasons," UnitedHealth Group announced on May 13. The company tapped Stephen J. Hemsley, who served as its CEO from 2006 to 2017, to replace ...

UnitedHealth Group CEO Andrew Witty stepped down from his executive role in May 2025. The company announced his successor that month in a press release and cited the reason for Witty’s departure.

Witty was well rewarded for those efforts, bringing in $26.3 million in compensation in 2024, making him one of the highest-paid CEOs in healthcare. Now, Witty is being replaced by Hemsley ...

UnitedHealth Group CEO Andrew Witty will step down from his role at the top of the company due to personal reasons, the healthcare giant announced Tuesday morning. Stephen Hemsley, who previously ...

Andrew Witty, the former CEO of UnitedHealth Group, earned approximately $25 million in total compensation in 2023 ( Reuters) UnitedHealth Group announced on Tuesday, May 13, that CEO Andrew Witty ...

. Before joining UnitedHealth Group, he served as CEO of GlaxoSmithKline (GSK) from 2008 to 2017 (Reuters) UnitedHealth Group’s shares plunged over 10% in premarket trading on Tuesday after the ...

Mary Cunningham is a reporter for CBS MoneyWatch. Before joining the business and finance vertical, she worked at "60 Minutes," CBSNews.com and CBS News 24/7 as part of the CBS News Associate Program.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Former GlaxoSmithKline chief executive Sir Andrew Witty has taken a leave of absence from his current day job to lead the push to develop vaccines for COVID-19 at the World Health Organization (WHO).